Stock Fundamentals

Company Information

Company Name
Citius Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US17322U2078
CIK: 0001506251
CUSIP: 17322U207
Currency: USD
Full Time Employees: 23
Phone: 908 967 6677
Fiscal Year End: September
IPO Date: Jul 06, 2017
Description:

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Address:

11 Commerce Drive, Cranford, NJ, United States, 07016

Directors & Officers

Name Title Year Born
Mr. Leonard L. Mazur Co-Founder, CEO, Chairman & Secretary 1945
Mr. Myron Z. Holubiak Co-Founder & Executive Vice Chairman 1947
Dr. Myron S. Czuczman M.D. Executive VP & Chief Medical Officer 1960
Mr. Jaime Bartushak Chief Business Officer & CFO 1968
Mr. Gary F. Talarico Executive Vice President of Operations 1955
Ms. Ilanit Allen Vice President of Investor Relations & Corporate Communications NA
Dr. Alan Lader Ph.D. Senior VP and Head of Clinical Operations & Quality Assurance NA
Mr. Dhananjay G. Wadekar Senior Vice President of Business Strategy 1954
Mr. Kelly Creighton Ph.D. Executive Vice President of Chemistry, Manufacturing & Controls NA
Mr. Nikolas Burlew Executive Vice President of Quality Assurance NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 27, 2019 Leonard L Mazur N/A Purchase 2.23M $0.90 $2.01M
Sep 27, 2019 Myron Z Holubiak N/A Purchase 558.60K $0.90 $502.74K
Sep 25, 2019 Myron Z Holubiak N/A Purchase 5.00K $6.02 $30.10K
Apr 03, 2019 Leonard L Mazur N/A Purchase 1.17M $1.55 $1.81M
Apr 03, 2019 Myron Z Holubiak N/A Purchase 129.45K $1.55 $200.65K
Aug 13, 2018 Myron Z Holubiak N/A Purchase 784.31K $1.28 $1.00M
Mar 28, 2018 Myron Z Holubiak N/A Purchase 2.92K $3.09 $9.01K
Aug 24, 2017 Leonard L Mazur N/A Purchase 11.00K $2.68 $29.48K
Aug 08, 2017 Leonard L Mazur N/A Purchase 421.40K $4.13 $1.74M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Geode Capital Management, LLC 246.16K Mar 31, 2026 0.90% $0.00 93.02%
Vanguard Group Inc 199.26K Dec 31, 2025 0.73% $0.00 19.75%
BlackRock Inc 69.85K Mar 31, 2026 0.25% $0.00 0.00%
HRT FINANCIAL LLC 60.33K Mar 31, 2026 0.22% $0.00 0.00%
Asset Advisory Group, INC. 59.01K Mar 31, 2026 0.22% $0.03 0.00%
UBS Group AG 55.03K Mar 31, 2026 0.20% $0.00 -28.01%
Northern Trust Corp 43.97K Mar 31, 2026 0.16% $0.00 0.00%
Susquehanna International Group, LLP 36.84K Mar 31, 2026 0.13% $0.00 185.61%
LPL Financial Corp 25.05K Mar 31, 2026 0.09% $0.00 -0.09%
State Street Corp 23.27K Mar 31, 2026 0.08% $0.00 0.00%
Jane Street Group LLC 22.52K Mar 31, 2026 0.08% $0.00 25.42%
XTX Topco Ltd 21.30K Mar 31, 2026 0.08% $0.00 -80.12%
Scientech Research LLC 20.90K Dec 31, 2025 0.08% $0.01 0.00%
Arkadios Wealth Advisors 20.00K Mar 31, 2026 0.07% $0.00 0.00%
Miller Financial Services LLC 14.00K Mar 31, 2026 0.05% $0.01 0.00%
Two Sigma Investments LLC 13.14K Mar 31, 2026 0.05% $0.00 -78.40%
IFP Advisors, LLC 7.08K Mar 31, 2026 0.03% $0.00 0.00%
SBI Securities Co Ltd 6.52K Mar 31, 2026 0.02% $0.00 62.24%
Citigroup Inc 5.23K Mar 31, 2026 0.02% $0.00 520.17%
Chelsea Management Company 4.63K Mar 31, 2026 0.02% $0.00 0.00%

Shares Statistics

Shares Outstanding: 27.45M
Shares Float: 26.96M
% Insiders: 179.50%
% Institutions: 363.20%
Short % Float: 19.15%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 170.87K 0.62% ▲ 70.27% Mar 31, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 167.74K 0.61% ▲ 0.00% Apr 30, 2026
3 Abante Quant Value FI 64.00K 0.23% ▲ 0.00% Mar 31, 2026
4 Northern Trust Extended Eq Market Idx 38.25K 0.14% ▲ 79.59% Mar 31, 2026
5 NT Ext Equity Mkt Index Fund - Lending 38.25K 0.14% ▲ 0.00% Mar 31, 2026
6 Fidelity Series Total Market Index 26.36K 0.10% ▲ 33.67% Mar 31, 2026
7 Spartan Extended Market Index Pool F 25.15K 0.09% ▲ 3,417.90% Mar 31, 2026
8 NT Ext Eq Mkt Idx Fd DC Lending Tier 5 15.09K 0.06% ▲ 0.70% Mar 31, 2026
9 Spartan Total Market Index Pool G 12.08K 0.04% ▲ 0.00% Mar 31, 2026
10 Fidelity Total Market Index 11.66K 0.04% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $13.63M
Trailing P/E: 0.00
Forward P/E: 0.32

Financial Highlights

Market Cap: $16.71M
EBITDA: $-53.85M
PEG Ratio: $0.00
Book Value: $2.75
Earnings/Share: $-2.14
Profit Margin: 0.00%
Operating Margin: -1,827.78%
ROA (TTM): -27.63%
ROE (TTM): -83.60%
Revenue (TTM): $5.61M
Revenue/Share (TTM): $0.31
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-09-30 0.62x 0.02x 0.41x -143.87x -0.03x
2024-09-30 0.40x 0.01x 0.36x N/A -0.01x
2023-09-30 5.95x 0.00x 0.12x N/A -0.01x
2022-09-30 9.84x 0.00x 0.09x -132.52x -0.01x
2021-09-30 18.28x 0.00x 0.07x -2,171.04x -0.02x
2020-09-30 3.41x 0.01x 0.23x -1,130.01x -0.03x
2019-09-30 1.72x 0.01x 0.16x -948.63x -0.01x
2018-09-30 3.16x 0.01x 0.10x -870.64x -0.01x
2017-09-30 1.39x 0.01x 0.10x -11.74x -0.02x
2016-09-30 0.17x 0.04x 0.24x -828.25x -0.09x
2015-09-30 0.53x -1.16x 1.86x -430.66x -0.23x
2014-09-30 0.67x -0.81x 1.48x N/A N/A
2013-09-30 6.98x -0.22x 0.14x -8.65x -0.11x
2012-09-30 0.00x -0.37x 340.61x -8.22x -0.87x
2011-09-30 0.01x -0.78x 113.46x N/A -0.74x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CTXR.US!